| Towards harmonization: the European biotechnology patent directive. | |
| | |
MedLine Citation:
|
PMID: 12816122 Owner: KIE Status: MEDLINE |
Abstract/OtherAbstract:
|
Having first been proposed over a decade ago to harmonize European patent law for the benefit of Europe's fledgling biotechnology industry, the Biotechnology Patent Directive underwent a somewhat tortured introduction to adolescence when its adoption was challenged by a legal annulment action from the Governments of the Netherlands, Italy and Norway. This article explores the nature of the legal challenge to the Directive, which to an extent typify European concerns about biotechnological inventions, particularly the "patenting of life." |
| | |
Authors:
|
Duncan Curley |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The journal of biolaw & business Volume: 5 ISSN: 1095-5127 ISO Abbreviation: J Biolaw Bus Publication Date: 2002 |
Date Detail:
|
Created Date: 2003-06-19 Completed Date: 2003-07-28 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9891884 Medline TA: J Biolaw Bus Country: United States |
Other Details:
|
Languages: eng Pagination: 64-8 Citation Subset: E |
Affiliation:
|
McDermott, Will & Emery, London, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Animals, Genetically Modified Biotechnology / ethics, legislation & jurisprudence* Europe Humans International Cooperation Italy Netherlands Norway Patents as Topic / ethics, legislation & jurisprudence* Plants, Genetically Modified |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Bioethics and the commodification of biotechnology.
Next Document: Central ethical dilemmas in research involving children.